Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cancers
|
March 14, 2026
Pharmacologic and Oncohistone Inhibition of SETD2 Converge on Genomic Instability
Alyssa T Paparella, Ashley G Boice, In Young Park, et al.
Nature Genetics
|
September 2, 2024
Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells
H Josh Jang, Nakul M Shah, Ju Heon Maeng, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Efficient profiling of total RNA in single cells with STORM-seq
Benjamin K Johnson, Mary F Majewski, H Josh Jang, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Dietary Restriction Enhances CD8<sup>+</sup> T Cell Ketolysis to Limit Exhaustion and Boost Anti-Tumor Immunity
Brandon M Oswald, Lisa M DeCamp, Joseph Longo, et al.
Nature Metabolism
|
December 9, 2025
Dietary restriction reprograms CD8<sup>+</sup> T cell fate to enhance anti-tumour immunity and immunotherapy responses
Brandon M Oswald, Lisa M DeCamp, Joseph Longo, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Leveraging Human Pangenome for Improved Somatic Variant Detection
Qichen Fu, Zilan Xin, Benpeng Miao, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.
Blood Neoplasia
|
June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
H Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cancers
|
March 14, 2026
Pharmacologic and Oncohistone Inhibition of SETD2 Converge on Genomic Instability
Alyssa T Paparella, Ashley G Boice, In Young Park, et al.
Nature Genetics
|
September 2, 2024
Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells
H Josh Jang, Nakul M Shah, Ju Heon Maeng, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Efficient profiling of total RNA in single cells with STORM-seq
Benjamin K Johnson, Mary F Majewski, H Josh Jang, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Dietary Restriction Enhances CD8<sup>+</sup> T Cell Ketolysis to Limit Exhaustion and Boost Anti-Tumor Immunity
Brandon M Oswald, Lisa M DeCamp, Joseph Longo, et al.
Nature Metabolism
|
December 9, 2025
Dietary restriction reprograms CD8<sup>+</sup> T cell fate to enhance anti-tumour immunity and immunotherapy responses
Brandon M Oswald, Lisa M DeCamp, Joseph Longo, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Leveraging Human Pangenome for Improved Somatic Variant Detection
Qichen Fu, Zilan Xin, Benpeng Miao, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.
Blood Neoplasia
|
June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
H Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Page
of 2